A low CD4/CD8 ratio has been associated to AIDS and non-AIDSassociated events. Long-term side effects have led to non-conventional NRTIsparingregimens. Aim of the study was to evaluate if the switch to mono/dualtherapy could determine a change in CD4/CD8 ratio.
CD4/CD8 ratio in patients who switch cART therapy: triple drug regimen could be better than mono/dual?
G. NunnariMembro del Collaboration Group
;
2017-01-01
Abstract
A low CD4/CD8 ratio has been associated to AIDS and non-AIDSassociated events. Long-term side effects have led to non-conventional NRTIsparingregimens. Aim of the study was to evaluate if the switch to mono/dualtherapy could determine a change in CD4/CD8 ratio.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
